77 related articles for article (PubMed ID: 3360570)
1. An experimental and clinical study of immunocompetence and immunostimulation in breast cancer.
Reynier J; Bazin JC; Bizzini B; Villet R; Chany C; Leandri S
Int Surg; 1988; 73(1):10-5. PubMed ID: 3360570
[TBL] [Abstract][Full Text] [Related]
2. [Carcinoma of the breast. Immune behaviour. Immunostimulation by fraction P40 (author's transl)].
Reynier J; Bazin JC; Bizzini B; Gandrille C; Guettier C; Henocq E; Hollmann K; Mogenet M; Pompidou A; Santus JP; Verley JM; Villet R
Chirurgie; 1980 Jan; 106(1):48-55. PubMed ID: 7379633
[No Abstract] [Full Text] [Related]
3. [Breast cancer: a dynamic approach of cellular immunity and immunostimulation with an immunoadjuvant: P40 fraction. (author's transl)].
Santus JP; Henocq E; Bizzini B; Bazin JC; Mogenet M; Villet R; Reynier J
Pathol Biol (Paris); 1979 Sep; 27(7):395-401. PubMed ID: 388318
[TBL] [Abstract][Full Text] [Related]
4. Immunocompetence, immunosuppression, and human breast cancer. III. Prognostic significance of initial level of immunocompetence in early and advanced disease.
Adler A; Stein JA; Ben-Efraim S
Cancer; 1980 Apr; 45(8):2074-83. PubMed ID: 7370953
[TBL] [Abstract][Full Text] [Related]
5. Immunological investigation and immunotherapy in patients operated on for breast carcinoma.
Reynier J; Villet R; Bazin JC; Bizzini B; Gandrille C; Guettier C; Henocq E; Hollmann K; Mogenet M; Pompidou A; Santus JP; Verley JM
Int Surg; 1982; 67(1):17-24. PubMed ID: 7095998
[TBL] [Abstract][Full Text] [Related]
6. [Role of chemotherapy in adjuvant treatment of breast cancer: modulation of the immune status].
Fargeot P; Guerrin J
Bull Cancer; 1984; 71(4):346-53. PubMed ID: 6388673
[TBL] [Abstract][Full Text] [Related]
7. Immunocompetence, immunosuppression, and human breast cancer. II. Further evidence of initial immune impairment by integrated assessment effect of nodal involvement (N) and of primary tumor size (T).
Adler A; Stein JA; Ben-Efraim S
Cancer; 1980 Apr; 45(8):2061-73. PubMed ID: 7370952
[TBL] [Abstract][Full Text] [Related]
8. Adrenalectomy and oophorectomy plus limited-term chemotherapy in the treatment of breast cancer.
Hoge AF; Bottomley RH; Shaw MT; Asal NR
Cancer Treat Rep; 1976 Jul; 60(7):857-65. PubMed ID: 1009519
[TBL] [Abstract][Full Text] [Related]
9. [Remote lymph nodes in the immunodiagnosis of cancer of the breast (prognostic value)].
Sarría JA; Cismondi B; Irigoyen ML; Spitale L
Rev Fac Cien Med Univ Nac Cordoba; 1982; 40(3-4):3-18. PubMed ID: 6927027
[No Abstract] [Full Text] [Related]
10. DNCB and PPD skin tests and prognosis in 152 patients with breast cancer. A prospective 2-year follow-up.
Munzarová M; Kovarík J; Hlávková J; Popelínský L; Lauerová L
Neoplasma; 1985; 32(1):45-50. PubMed ID: 3982560
[TBL] [Abstract][Full Text] [Related]
11. Tumor immune subtypes distinguish tumor subclasses with clinical implications in breast cancer patients.
de Kruijf EM; Engels CC; van de Water W; Bastiaannet E; Smit VT; van de Velde CJ; Liefers GJ; Kuppen PJ
Breast Cancer Res Treat; 2013 Nov; 142(2):355-64. PubMed ID: 24197659
[TBL] [Abstract][Full Text] [Related]
12. Immunological enhancement of breast cancer.
Stewart TH; Heppner GH
Parasitology; 1997; 115 Suppl():S141-53. PubMed ID: 9571699
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the antitumor effects of a synthetic biopolymer and standard adjuvants.
Falk RE; Makowka L; Nossal NA; Rotstein LE; Falk JA
Surgery; 1980 Jul; 88(1):126-36. PubMed ID: 6992317
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant breast cancer vaccine improves disease specific survival of breast cancer patients with depressed lymphocyte immunity.
Elliott RL; Head JF
Surg Oncol; 2013 Sep; 22(3):172-7. PubMed ID: 23791552
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the immune status in patients with breast carcinoma].
Armellino F; Malanetto C; Girotto M; Rossetto P; Francisco G
Minerva Ginecol; 1986 Oct; 38(10):811-4. PubMed ID: 3808412
[No Abstract] [Full Text] [Related]
16. Relative and age-dependent stimulation of soluble and cellular immunity in opiate dependence.
Reece AS
J Addict Med; 2012 Mar; 6(1):10-7. PubMed ID: 21918466
[TBL] [Abstract][Full Text] [Related]
17. Experimental and clinical results with the Corynebacterium granulosum-derived immunomodulator P40.
Bizzini B; Henocq E; Reynier J; Relyveld EH
Asian Pac J Allergy Immunol; 1984 Jun; 2(1):144-53. PubMed ID: 6529476
[No Abstract] [Full Text] [Related]
18. [Effect of immunomodifier on radiation-induced antitumor immunity following local irradiation to tumor--2. Mouse interferon-alpha/beta].
Mukae S; Norimura T; Tsuchiya T
Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Oct; 48(10):1243-8. PubMed ID: 3222138
[No Abstract] [Full Text] [Related]
19. Long-term follow-up of general immune competence in breast cancer. II. Sequential pre- and post-treatment levels: a 10 year study.
Shukla HS; Hughes LE; Whitehead RH; Newcombe RG
Cancer Immunol Immunother; 1986; 21(1):6-11. PubMed ID: 3632917
[TBL] [Abstract][Full Text] [Related]
20. Long-term (5-11 years) follow-up of general immune competence in breast cancer. I. Pre-treatment levels with reference to micrometastasis.
Shukla HS; Hughes LE; Whitehead RH; Newcombe RG
Cancer Immunol Immunother; 1986; 21(1):1-5. PubMed ID: 3632914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
